NCT00408395View on ClinicalTrials.gov

Safety and Immunogenicity of 2 Commercially Available Influenza Vaccines in Children

PHASE2CompletedINTERVENTIONAL

Enrollment

281

Participants

Timeline

Start Date

November 30, 2006

Primary Completion Date

August 31, 2007

Study Completion Date

August 31, 2007

Conditions

Influenza

Interventions

BIOLOGICAL

Influenza vaccine

Seasonal Influenza Vaccine

Trial Locations (1)

33014

University of Tampere Medical School, Tampere

Sponsors

Lead Sponsor

Novartis Vaccines

All Listed Sponsors

lead

Novartis Vaccines

INDUSTRY